Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill (AP) platform technology. The company's Accordion Pill is an oral drug-delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

The company's product pipeline includes two candidates in clinical development: Accordion Pill Carbidopa/Levodopa, which recently completed a phase-3 trial for the treatment of Parkinson's disease symptoms in patients with advanced Parkinson's disease, and AP-cannabinoids, a system to deliver either or both of the primary cannabinoids contained in Cannabis sativa for various indications including cancer pain and opioid-sparing pain management.